Find information on thousands of medical conditions and prescription drugs.

Babesiosis

Babesiosis is a rare malaria-like parasitic disease caused by protozoan parasites of the genus Babesia, which belongs to the phylum Apicomplexa. While more than 100 species have been reported, only a few have been identified as causing human infections. Babesia microti and Babesia divergens have been identified in most human cases, but variants (considered different species) have been recently identified. The protozoan was first identified in 1888 by Romanian biologist, Victor Babeş, after whom the genus is named. Little is known about the occurrence of Babesia species in malaria-endemic areas where Babesia can easily be misdiagnosed as Plasmodium.

Home
Diseases
A
B
Babesiosis
Bacterial endocarditis
Bacterial food poisoning
Bacterial meningitis
Bacterial pneumonia
Balantidiasis
Bangstad syndrome
Bardet-Biedl syndrome
Bardet-Biedl syndrome
Bardet-Biedl syndrome
Bardet-Biedl syndrome
Barrett syndrome
Barth syndrome
Basal cell carcinoma
Bathophobia
Batrachophobia
Batten disease
Becker's muscular dystrophy
Becker's nevus
Behcet syndrome
Behr syndrome
Bejel
Bell's palsy
Benign congenital hypotonia
Benign essential tremor...
Benign fasciculation...
Benign paroxysmal...
Berdon syndrome
Berger disease
Beriberi
Berylliosis
Besnier-Boeck-Schaumann...
Bibliophobia
Bicuspid aortic valve
Biliary atresia
Binswanger's disease
Biotinidase deficiency
Bipolar disorder
Birt-Hogg-Dube syndrome
Blastoma
Blastomycosis
Blepharitis
Blepharospasm
Bloom syndrome
Blue diaper syndrome
Blue rubber bleb nevus
Body dysmorphic disorder
Boil
Borreliosis
Botulism
Bourneville's disease
Bowen's disease
Brachydactyly
Brachydactyly type a1
Bradykinesia
Bright's disease
Brittle bone disease
Bromidrosiphobia
Bronchiectasis
Bronchiolotis obliterans...
Bronchopulmonary dysplasia
Brown-Sequard syndrome
Brucellosis
Brugada syndrome
Bubonic plague
Budd-Chiari syndrome
Buerger's disease
Bulimia nervosa
Bullous pemphigoid
Burkitt's lymphoma
Byssinosis
Cavernous angioma
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Read more at Wikipedia.org


[List your site here Free!]


Babesiosis Coinfection Changes Lyme Disease Management - Brief Article
From Family Pratice News, 11/1/00 by Mitchel L. Zoler

TORONTO -- Patients with moderate to severe Lyme disease could be coinfected by the agent that causes babesiosis, Dr. Charles Thompson reported in a poster at the annual Interscience Conference on Antimicrobial Agents and Chemotherapy sponsored by the American Society for Microbiology.

Babesiosis coinfection can exacerbate the symptoms of Lyme disease. It is important to diagnose babesiosis because treatments for the two infections are completely different, Dr. Paul Krause, who collaborated on the study, said in an interview with this newspaper.

The first-line treatment for Lyme disease in adults is 100 mg doxycycline b.i.d. The first-line treatment for babesiosis is 600 mg clindamycin t.i.d. and 650 mg quinine t.i.d. An alternative treatment for babesiosis in adults is azithromycin plus atovaquone, said Dr. Krause, an infectious diseases physician at Connecticut Children's Medical Center, Hartford.

Patients with Lyme disease who are coinfected with another tick-borne pathogen, the agent that causes human granulocytic ehrlichiosis (HGE), also develop more severe symptoms. But in these cases standard treatment for HGE is the same as it is for Lyme disease, Dr. Krause said.

The clinical consequences of coinfection were examined in a series of 185 adults who were diagnosed with Lyme disease, babesiosis, or HGE during May-Sept. of 1997-2000. The cases were culled from three regions of New England: Block Island, Nantucket, and southeastern Connecticut.

Lyme disease alone occurred in 91 patients, who had a mean of 5.3 symptoms and a disease duration of 3.5 weeks. In contrast, the 65 patients with Lyme disease and babesiosis had a mean of 7.4 symptoms and a mean disease duration of 5.4 weeks, reported Dr. Thompson, a pediatrician at the medical center.

Seven patients had Lyme disease and HGE. They had a mean of 7.4 symptoms, and their infections persisted for a mean of 4.5 weeks. The three patients with babesiosis and HGE simultaneously had a mean of 10 symptoms for a mean of 8 weeks. Four patients had all three diseases at once. They had a mean of 8.3 symptoms for a mean of 5 weeks.

The series was rounded out with 14 patients with babesiosis only, with a mean of 8.4 symptoms for a mean of 7.4 weeks. One patient had HGE only. This patient had five symptoms, but the duration of illness was not known. Coinfection with the agents that cause either babesiosis or HGE worsens symptoms in patients with Lyme disease. In contrast, coinfection with the Lyme disease pathogen does not worsen the course of babesiosis or HGE.

One of the easiest ways to identify patients who have Lyme disease is by the presence of erythema migrans, a bull's-eye rash. In this series, 86% of the patients with Lyme disease had erythema migrans, but the rash did not appear in any of the patients in this series who did not have Lyme disease, Dr. Thompson reported.

COPYRIGHT 2000 International Medical News Group
COPYRIGHT 2001 Gale Group

Return to Babesiosis
Home Contact Resources Exchange Links ebay